HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by ROSENQUIST, T. H. Articles by MONAGHAN, D. T. Search for Related Content PubMed PubMed Citation Articles by ROSENQUIST, T. H. Articles by MONAGHAN, D. T.

N-methyl-D-aspartate receptor agonists modulate homocysteine-induced developmental abnormalities

University of Nebraska Medical Center, Omaha, Nebraska 68198-6395, USA

¹Correspondence: Department of Cell Biology and Anatomy, The University of Nebraska Medical Center, 600 South 42nd St., Omaha, NE 68198-6395. E-mail: throsenq{at}unmc.edu

We showed previously that the induction of neural crest (NC) and neural tube (NT) defects is a general property of N-methyl-D-aspartate receptor (NMDAR) antagonists. Since homocysteine induces NC and NT defects and can also act as an NMDAR antagonist, we hypothesized that the mechanism of homocysteine-induced developmental defects is mediated by competitive inhibition of the NMDAR by homocysteine. If this hypothesis is correct, homocysteine-induced defects will be reduced by NMDAR agonists. To test the hypothesis, we treated chicken embryos during the process of neural tube closure with sufficient homocysteine thiolactone to induce NC and NT defects in ~40% of survivors or with homocysteine thiolactone in combination with each of a selected set of NMDAR agonists in 0.05–5000 nmol doses. Glutamate site agonists selected were L-glutamate and N-methyl-D-aspartate. Glycine site agonists were glycine, D-cycloserine, and aminocyclopropane-carboxylic acid. Glycine was the most effective overall, reducing defects significantly at two different doses (each P>0.001). These results support the hypothesis that homocysteine may affect NC and NT development by its ability to inhibit the NMDAR. One potentially important consequence of this putative mechanism is that homocysteine may interact synergistically with other NMDAR antagonists to enhance its effect on development.—Rosenquist, T. H., Schneider, A. M., and Monaghan, D. T. N-methyl-D-aspartate receptor agonists modulate homocysteine-induced developmental abnormalities.

Key Words: neural tube defects • neural crest defects • orofacial defects • prevention

This article has been cited by other articles:

				G. Neeman, M. Blanaru, B. Bloch, I. Kremer, M. Ermilov, D. C. Javitt, and U. Heresco-Levy Relation of Plasma Glycine, Serine, and Homocysteine Levels to Schizophrenia Symptoms and Medication Type Am J Psychiatry, September 1, 2005; 162(9): 1738 - 1740. [Abstract] [Full Text] [PDF]

				I. A. L. M. van Rooij, C. Vermeij-Keers, L. A. J. Kluijtmans, M. C. Ocke, G. A. Zielhuis, S. M. Goorhuis-Brouwer, J.-J. van der Biezen, A.-M. Kuijpers-Jagtman, and R. P. M. Steegers-Theunissen Does the Interaction between Maternal Folate Intake and the Methylenetetrahydrofolate Reductase Polymorphisms Affect the Risk of Cleft Lip with or without Cleft Palate? Am. J. Epidemiol., April 1, 2003; 157(7): 583 - 591. [Abstract] [Full Text] [PDF]

				K. Robert, F. Vialard, E. Thiery, K. Toyama, P.-M. Sinet, N. Janel, and J. London Expression of the Cystathionine {beta} Synthase (CBS) Gene During Mouse Development and Immunolocalization in Adult Brain J. Histochem. Cytochem., March 1, 2003; 51(3): 363 - 371. [Abstract] [Full Text] [PDF]